Susquehanna International Group
HLVX

Susquehanna International Group’s HilleVax HLVX Stock Holding History

Susquehanna International Group’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,606
Closed -$23.1K – 13025
2025
Q2 		$23.1K Sell
11,606
-33,526
-74% -$61.3K ﹤0.01% 12306
2025
Q1 		$65.4K Buy
45,132
+31,298
+226% +$57.8K ﹤0.01% 11768
2024
Q4 		$28.6K Sell
13,834
-1,091
-7% -$2.05K ﹤0.01% 11845
2024
Q3 		$26.3K Buy
+14,925
New +$38.3K ﹤0.01% 11564
2024
Q1 		– Sell
-12,910
Closed -$207K – 12648
2023
Q4 		$207K Buy
+12,910
New +$172K ﹤0.01% 10608
2023
Q2 		– Sell
-10,539
Closed -$174K – 12509
2023
Q1 		$174K Buy
+10,539
New +$169K ﹤0.01% 10764
2022
Q3 		– Sell
-22,890
Closed -$250K – 13579
2022
Q2 		$250K Buy
+22,890
New +$272K ﹤0.01% 10055

Susquehanna International Group's HLVX Position: Q3 2025 in Review

Susquehanna International Group sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 11,606 shares — an estimated $23.1K sold.

Susquehanna International Group first reported a position in HLVX in Q2 2022 and held it in 7 quarters. The position peaked at $250K in Q2 2022. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Susquehanna International Group reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 11,606 HilleVax shares in Q3 2025, an estimated $23.1K.
  • Susquehanna International Group first reported a position in HilleVax in Q2 2022 and held it in 7 quarters.
  • Susquehanna International Group's HilleVax position peaked at $250K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.